Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2023-07-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Correlation of Optic Disk Morphology and Ocular Perfusion Parameters in Patients With Primary Open Angle Glaucoma
NCT00803504
Functional and Structural Imaging for Glaucoma
NCT01957267
Ultrastructural Changes of Trabeculectomy Specimens in Patients With Uveitic Secondary Glaucoma
NCT00917670
Central Corneal Thickness in Glaucoma
NCT01023997
Long-term Vascular, Functional and Morphological Changes in Glaucoma and Ocular Hypertensive Patients
NCT06827535
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Optical coherence tomography
Heidelberg Engineering Spectralis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Diabetes
* Pregnancy
* Hypertensive retinopathy
* Smoking
* Intraocular surgery 1 month prior to study entry
* Systemic or ocular disease, excluding glaucoma, which the investigator believes could affect the test results
* Insufficient quality of the optical coherence tomography imaging
* Insufficient cooperation during examinations or measurements
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vienna Hospital Association
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prim. Univ.-Prof. Dr. Pia Veronika Vécsei-Marlovits, MSc, MB
Head of Department of Ophthalmology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pia V Vécsei-Marlovits, MD, MSc, MBA
Role: PRINCIPAL_INVESTIGATOR
Department of Ophthalmology, Clinic Hietzing, Vienna Healthcare Group
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Ophthalmology, Clinic Hietzing, Vienna Healthcare Group
Vienna, Vienna, Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
struct_funct_glaucoma
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.